ストックスクリーナーアプリを入手
1.05
1.94%
0.02
前日終値:
$1.03
開ける：
$1.0561
24時間の取引高:
133.92K
Relative Volume:
0.51
時価総額：
$14.49M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+8.25%
1か月 パフォーマンス:
+27.29%
6か月 パフォーマンス:
+48.31%
1年 パフォーマンス:
-97.49%
1日の値動き範囲:
$1.04
$1.12
1週間の範囲:
$0.94
$1.13
52週間の値動き範囲:
$0.375
$45.29
AEON Biopharma Inc. Stock (AEON) Company Profile
AEON を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
1.05 | 14.21M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.99 | 116.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.71 | 82.52B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.69 | 52.67B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
849.95 | 52.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.42 | 37.70B | 447.02M | -1.18B | -906.14M | -6.1812 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-08-18 | 開始されました | H.C. Wainwright | Buy |
AEON Biopharma Inc. (AEON) 最新ニュース
Aug EndMonth: How AEON Biopharma Inc stock benefits from global expansionWeekly Profit Recap & Risk Managed Investment Strategies - moha.gov.vn
Will AEON Biopharma Inc. stock split attract more investorsSwing Trading Ideas & Low Cost Portfolio Tips - Bollywood Helpline
Is AEON Biopharma Inc. Class stock bottoming after sell offBond Market & Community Verified Trade Signals - Улправда
Investor Mood: Can AEON Biopharma Inc. Class stock stage a strong rebound this quarter - Улправда
Can AEON Biopharma Inc. Class stock stage a strong rebound this quarterTrade Ideas & Long-Term Growth Plans - Улправда
Will AEON Biopharma Inc. Class stock benefit from infrastructure billWeekly Trading Summary & Reliable Breakout Stock Forecasts - Улправда
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - The Manila Times
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - GlobeNewswire Inc.
How AEON Biopharma Inc. Class stock compares with tech leadersJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - Улправда
Midday Stock Roundup: Rivian Stock Continues to Climb - Orange County Business Journal
Is AEON Biopharma Inc. Class stock undervalued historicallyEarnings Overview Summary & Pattern Based Trade Signal System - DonanımHaber
Will AEON Biopharma Inc. Class stock sustain dividend payoutsJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - DonanımHaber
Will AEON Biopharma Inc. stock recover faster than marketMarket Sentiment Review & Smart Allocation Stock Reports - DonanımHaber
How AEON Biopharma Inc. stock benefits from global expansionJuly 2025 Market Mood & Fast Gain Stock Tips - Улправда
What insider trading reveals about AEON Biopharma Inc. stockPortfolio Update Summary & AI Enhanced Market Trend Forecasts - Улправда
AEON Biopharma IncExchange to Eliminate Ov - 富途牛牛
AEON Biopharma announces execution of exchange agreement with Daewoong Pharmaceutical - MSN
Aeon Biopharma announces execution of exchange agreement with Daewoong - marketscreener.com
AEON Biopharma Announces Exchange Agreement with Daewoong - TipRanks
AEON Biopharma announces exchange agreement with Daewoong - MSN
AEON Biopharma Announces Execution of Exchange Agreement with Daewoong - The Manila Times
AEON Biopharma signs Daewoong note exchange with equity and warrants | AEON SEC FilingForm 8-K - Stock Titan
AEON Biopharma (NYSE: AEON) agrees Daewoong swap cutting over 90% of debt - Stock Titan
Aeon Biopharma Continues Push to Commercialization - Orange County Business Journal
AEON Biopharma (AEON) Price Target Decreased by 15.28% to 6.22 - Nasdaq
How AEON Biopharma Inc. Class stock performs in volatility spikesQuarterly Market Review & Fast Gain Stock Trading Tips - Newser
Can AEON Biopharma Inc. Class stock retain market dominanceJuly 2025 Summary & Trade Opportunity Analysis Reports - Newser
AEON Biopharma Releases New Corporate Presentation - TipRanks
AEON Biopharma : Corporate Presentation - marketscreener.com
AEON Biopharma (NYSE: AEON) releases new investor Corporate Presentation - Stock Titan
AEON Biopharma, Inc. Releases Corporate Presentation on Biosimilar Development - TradingView
Aeon Biopharma Reports Positive Data and Strategic Moves - MSN
Aeon Secures Funding As FDA Sets New Date For Botox Biosimilar Review - Citeline News & Insights
Check out these key findings about AEON Biopharma Inc (AEON) - Setenews
How AEON Biopharma Inc. Class stock valuation compares with sector2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com
AEON Biopharma (NASDAQ:AEON) Upgraded at Zacks Research - Defense World
Aeon Biopharma announces first closing of PIPE investment and provides update on FDA Type 2A meeting scheduling - MarketScreener
Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling - TradingView
AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling - The Manila Times
AEON Biopharma Inc: FDA Bpd Type 2a Meeting N - 富途牛牛
Can AEON Biopharma Inc. Class stock survive global slowdownWeekly Profit Analysis & Expert Curated Trade Setup Alerts - newser.com
Will AEON Biopharma Inc. Class stock beat international competitionWeekly Earnings Recap & Capital Protection Trading Alerts - newser.com
Applying big data sentiment scoring on AEON Biopharma Inc.July 2025 PostEarnings & Verified Short-Term Plans - newser.com
Why AEON Biopharma Inc. Class stock signals breakout potentialPortfolio Gains Summary & Smart Allocation Stock Reports - newser.com
Will AEON Biopharma Inc. Class stock announce special dividendBreakout Watch & Verified High Yield Trade Plans - newser.com
Will AEON Biopharma Inc. Class stock return to pre crash levelsTrade Risk Report & Free Expert Approved Momentum Trade Ideas - newser.com
What earnings margins imply for AEON Biopharma Inc. Class stockMarket Performance Summary & AI Enhanced Trade Execution Alerts - newser.com
Is AEON Biopharma Inc. Class stock among top earnings plays2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com
How forex fluctuations impact AEON Biopharma Inc. Class stockJuly 2025 Volume & Weekly Market Pulse Alerts - newser.com
AEON Biopharma Inc. (AEON) 財務データ
AEON Biopharma Inc. (AEON) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.36%
0.21%
大文字化:
|
ボリューム (24 時間):